Company: JUNS
Filing Date: 2025-11-06
Form Type: DEF 14A
Source: 0001493152-25-020988
Chunk: 17

Company: JUPITER NEUROSCIENCES, INC.
Filing Date: 2025-11-06
Form: DEF 14A
Chunk 17
---
 request to the Chief Administrative Officer of the Company.

Excluding Proposal No. 1 (Election of Directors), do the Company’s executive officers and Directors have an interest in any of the matters to be acted upon at the Annual Meeting?

No.

Are any of the proposals conditioned on one another?

No.

| -9- |

<div align='center'>PROPOSAL NO. 1:

ELECTION OF DIRECTORS</div>

Our Board currently consists of seven (7) directors, and their terms will expire at the virtual Annual Meeting. Directors are elected at the virtual Annual Meeting of stockholders each year and hold office until such director’s successor is elected and qualified, or until such director’s earlier death, resignation or removal.

Christer Rosén, Marshall Hayward, Ph.D., Alison D. Silva, Nicholas H. Hemmerly, Julie Kampf, Allison W. Brady, and Holger Weis have each been nominated to serve as directors and have agreed to stand for election. If these nominees are elected at the Annual Meeting, then each nominee will serve for a term expiring at the 2026 annual meeting of stockholders and until his or her successor is duly elected and qualified. Our Bylaws provide for a majority vote standard for uncontested director elections. Director nominees will be elected by a majority of the votes cast. A “majority of the votes cast” means that the number of votes cast “for” a director nominee exceeds the number of votes cast “against” such director nominee, with “abstentions” and “broker non-votes” not counted as a vote cast either “for” or “against” that nominee’s election. However, director nominees will be elected by a plurality of the votes cast in connection with a contested election.

If no contrary indication is made, proxies will be voted “ FOR” all nominees listed below or, in the event that any such individual is not a candidate or is unable to serve as a director at the time of the election (which is not currently expected), for any nominee who is designated by our Board to fill the vacancy.

Nominees for Election to the Board for a Term Expiring at the 2026 Annual Meeting of Stockholders

| Name           |     | Age |     | Positions                                      |
| Christer       
 Rosén          |     |  74 |     | Chairman                                       
 of Board, Chief Executive Officer and Director |
| Marshall       
 Hayward, Ph.D. |     |  70 |     | Chief                                          
 Scientific Officer